Iavi.org Website Review

Translating scientific discoveries into affordable, accessible public health solutions new approaches to developing vaccines and other means of preventing HIV. translational and clinical research through our laboratories in the U.S., India, and the U.K. in-country for researching vaccine candidates while strengthening local public health and scientific expertise. with industry and enlist biopharma product development skills to develop innovative products tailored to target populations. IAVI’s resources with other innovators to help the HIV community as a whole succeed. IAVI’s core capabilities to solving disease prevention and treatment challenges. Scientists are more optimistic than ever about developing HIV vaccines and antibody-based products. IAVI recognizes the Danish government for its continued commitment to HIV vaccine research and applauds the dedication of the Danish Ministry of Foreign Affairs to global health research and development. New partnership aims to make antibody prophylaxis for HIV more feasible and affordable. Collaboration to develop optimal combination of HIV-specific antibodies and ensure that cost is not a barrier to access After decades of research, renewed promise emerges for developing vaccines against the world’s deadliest infectious disease. IAVI staff explain why an HIV vaccine is the best way to end to the epidemic. ©2018 International AIDS Vaccine Initiative. All rights reserved. International AIDS Vaccine Initiative, IAVI, and the IAVI logo are trademarks of the International AIDS Vaccine Initiative, Inc.